| Name | Title | Contact Details |
|---|
Nivalis Therapeutics (formerly N30Pharma) is developing a novel class of disease modifying therapies that preserve intracellular GSNO (S-nitrosoglutathione), a key regulator of organ repair, regeneration, and healing. The Company’s lead program is focused on cystic fibrosis. As the body’s primary reservoir of nitric oxide (NO), GSNO plays a pivotal role in NO signaling. Decreased GSNO levels are associated with inflammatory lung disease, and with increased activity of GSNOR (GSNO reductase), the primary catabolizing enzyme of GSNO. Nivalis Therapeutics has developed a broad portfolio of proprietary, potent, small molecule inhibitors of GSNOR that have been shown to preserve endogenous GSNO levels and to be effective in “gold-standard” models of inflammatory lung disease. Nivalis Therapeutics is located in Boulder, Colorado.
Sirius Medicine is a Loveland, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Dearborn County Hospital is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Dearborn County Hospital is based in Lawrenceburg, IN. You can find more information on Dearborn County Hospital at www.dch.org
Cannus Partners Inc. operates as a specialty pharmaceutical company. The Company cultivates, processes, and distributes cannabis. Cannus Partners serves customers in the United States and Canada.
VetEvolve offers relationship-focused veterinary practice acquisition that helps you put the focus back on your patients with our superior business management.